In a previous study it has been observed that the analgesia of morphine was significantly decreased in rats that had been treated with pargyline daily for 6 days when morphine was administered 4 and 24 h after the last dose of pargyline 1. This phenomenon was hypothesized as being due to increasing the metabolism of morphine through an induction of glucuronyl transferase. This report presents the results of an investigation designed to examine this hypothesis.
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Pargyline: A,Glucuronyl Transferase Inducer
In a previous study it has been observed that the analgesia of morphine was significantly decreased in rats that had been treated with pargyline daily for 6 days when morphine was administered 4 and 24 h after the last dose of pargyline 1. This phenomenon was hypothesized as being due to increasing the metabolism of morphine through an induction of glucuronyl transferase. This report presents the results of an investigation designed to examine this hypothesis.
Materials and methods.
Holtzman male rats (150-170 g), kept in constant environmental condition and maintained on Wayne Lab-Blox (Allied Mills Inc.) and tap water ad libitum, were treated chronically with 75 mg/kg of pargyline (Abbott Laboratories), i.p. daily for 7 to 8 days. Control animals were injected with the same volume of saline.
24 h after the last injection the rats were sacrificed by a blow on the head and the livers immediately excized, immersed in ice cold 1.15% KC1 solution. The livers were blotted dry, weighed, placed in cold 1.15% KC1 solution, minced with scissors, and homogenized in cold 1.15 % KC1 solution with a Potter-Elvehjem homogenizer having a Teflon plunger in the cold to make a 20~ homogenate. The homogenate was centrifuged at 10,000 • for 20 min to remove the mitochondria, nuclei and unbroken cells. The supernatant was then centrifuged at 105,000 Xg for 60 min in a Spinco ultracentrifuge. The resultant pellet was resuspended in 1.15yo KC1 and centrifuged at 105,000 xg for 60 rain. Microsomes, equivalent to 1 g (wet weight) of liver, were suspended by gentle homogenization in 1 rnl of 1.15~ KC12. The protein content of tile microsomal suspension was determined according to the method of LOWRY et al. 3 with crystalline bovine albumin as standard.
The glucuronide formation of morphine was studied according to the method of AXELROD and INSCOE 4 except that the concentration of uridine diphosphate glucuronic acid (UDPGA) (Sigma Chemical Co.) was 6.7 ~moles instead of 0.8 ~moles. Incubation mixture contained 0.5 ml of microsomes, 5 • 10-3M MgC1 v 5 • 10-2M tris (hydroxymethyl)aminoethane buffer with a pH of 8.0, 2.5 • 10-4M of N-14C-methyl-morphine with and without 6.7 tzmoles (4 rag) of UDGPA and water to make a final volume of 2 ml. Incubations were carried out in 40 ml tubes in duplicate in Dubnoff-shaker at 37 ~ for 30 rain under atmosphere of air. The incubation was terminated by placing the tubes in a boiling water bath for 10 min and free morphine in the incubated samples were determined according to the procedure described previously 5. The amount of the glucuronide of morphine formed was calculated from the mean difference between the samples containing UDPGA and those without UDPGA. Enzyme activity was expressed as the amount of the glucuronide formed per 30 min per i mg of protein. A total of 7 animals were used, 4 of which had been treated for 7 days and 3 for 8 days with pargyline.
Student's t-test was used for comparison of the mean value of the glucuronide of morphine obtained from the liver microsomes of rats treated chronically with pargyline and with saline at p < 0.05 as the level of significance ".
Results and discussion. The glucuronide formation of morphine was significantly increased by liver microsomes obtained from the rats that had been treated chronically with pargyline (Table) . Both the body weight and liver weight were significantly less in the pargyline treated animals than in those receiving saline. However, the liver weight expressed as percent of body weight and the mg protein/g liver were not significantly different. Data obtained in the present study indicate that pargyline is a glucuronyl transferase inducer. The formation of the glucuronide of morphine by microsomes obtained from the pargyline chronic-treated rats was increased about 40% as compared with that obtained from saline control rats. To our knowledge, this is the first demonstration that pargyline is a glucuronyl transferase inducer. The mechanism of reduction of the analgesia of morphine in rats treated chronically with pargyline is probably due to an increased metabolism via glucuronide formation. This finding may well explain the reason that adverse reactions are seldom observed after administration of morphine to patients treated with monoamine oxidase inhibitorsT-l~ a Four animals were treated for 7 days and 3 for 8 days with pargyline, 75 mg/kg or saline, 2 ml/kg, daily. The data represent the mean • S.E. obtained from 7 animals ill each group, b Indicates significant difference between pargyline treated rats and that of the saline control rats at p ~ 0.05 level. ~ glueuronide formed n moles/30 min-mg protein.
